9 patents currently held
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Feb 2029. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Feb 2029
Next term end
7
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2032 · High confidence
Also notable
Ends Feb 2029 · High confidence
Also notable
Ends Nov 2038 · High confidence
PCR Methods for Characterizing the 5' Untranslated Region of the FMR1 and FMR2 Genes
US 8,679,757
Renewed at every maintenance window since the 2014 grant; no more fees are due before its term ends in 2032.
Method of Amplification of Gc-Rich DNA Templates
US 8,409,805
Renewed at every maintenance window since the 2013 grant; no more fees are due before its term ends in 2029.
Methods, Compositions, Kits, and Uses for Analysis of Nucleic Acids Comprising Repeating A/T-Rich Segments
US 11,214,829
The newest of the three, granted 2022. It anchors the portfolio to 2038, later than anything else here.
Formerly held, still cited
Notable
Ends Nov 2031 · High confidence
The most cited patent in this portfolio, cited by 32 later US patents, top 10% of utility patents granted in 2018 in our data. Protection runs to 2031.
now held by Interpace Diagnostics, LLC
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Aug 27, 2027The maintenance fee for Methods for Nucleic Acid Size Detection of Repeat Sequences (US 11,913,068) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Methods of RNA Amplification | 2 in force | to Oct 2038 |
| PCR Methods for Characterizing the 5' Untranslated Region of the FMR1 and FMR2 Genes | 2 in force | to Jul 2032 |
| Methods for Nucleic Acid Size Detection of Repeat Sequences | 1 in force | to Oct 2039 |
| Methods, Compositions, Kits, and Uses for Analysis of Nucleic Acids Comprising Repeating A/T-Rich Segments | 1 in force | to Nov 2038 |
| Method of Amplification of Gc-Rich DNA Templates | 1 in force | to Feb 2029 |
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,409,805 | Method of Amplification of Gc-Rich DNA Templates In force · High confidence | In force | High confidence | |
| US 9,783,848 | PCR Methods for Characterizing the 5' Untranslated Region of the FMR1 and FMR2 Genes In force · Medium confidence | In force | Medium confidence | |
| US 9,777,330 | mPCR Methods for Analyzing Repeat Sequences In force · High confidence | In force | High confidence | |
| US 8,679,757 | PCR Methods for Characterizing the 5' Untranslated Region of the FMR1 and FMR2 Genes In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 9,371,560 | Comprehensive FMR1 Genotyping In force (reinstated) · Medium confidence | In force (reinstated) | Medium confidence | |
| US 11,236,384 | Methods of RNA Amplification In force · High confidence | In force | High confidence | |
| US 12,139,755 | Methods of RNA Amplification In force · High confidence | In force | High confidence | |
| US 11,214,829 | Methods, Compositions, Kits, and Uses for Analysis of Nucleic Acids Comprising Repeating A/T-Rich Segments In force · High confidence | In force | High confidence | |
| US 11,913,068 | Methods for Nucleic Acid Size Detection of Repeat Sequences In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 2 patents in force now held by others · 25 patents ended · 2 applications pending · 45 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.